Sheba Medical center ( Site 1601)

Ramat Gan 5265601

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Malignant Neoplasms, Von Hippel-Lindau Disease

Studies at this site

• Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) — Recruiting now
• A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) — Recruiting now